US EditionPublished • loading... • Updated
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026
Kewaunee Scientific’s international segment grew 21.4%, boosting profitability despite a 2% domestic sales decline and integration costs from Nu Aire acquisition.
- On March 11, 2026, Kewaunee Scientific reported third‑quarter sales of $69,399,000, up 3.3% year‑over‑year, and diluted EPS of $0.23.
- Amid rising international billings, principally in India, international sales increased to $18,446,000, driven by billings in India, while domestic sales declined 2.0% to $50,953,000.
- The company recorded pre‑tax earnings of $1,604,000, and segment EBITDA data reveal international segment EBITDA increased to $1,963,000, while domestic segment EBITDA declined.
- Balance‑sheet metrics show cash on hand fell to $50,953,000 and working capital declined to $54,793,000 while short‑term debt increased to $7,351,000 as of January 31, 2026.
- The order backlog was $183.2 million on January 31, 2026, and the sale-leaseback building lease accounted for $25,988,000 of long-term debt, supporting ongoing growth strategies.
Insights by Ground AI
24 Articles
24 Articles
Coverage Details
Total News Sources24
Leaning Left2Leaning Right4Center9Last UpdatedBias Distribution60% Center
Bias Distribution
- 60% of the sources are Center
60% Center
13%
C 60%
R 27%
Factuality
To view factuality data please Upgrade to Premium
